Sign In
Buy LPTX
$0.690
+0 (+0%)
At Close: Jun 23, 2026
Leap Therapeutics Stock Is Moving Higher On Updated DKN-01 Combo Trial Data In Gastric Cancer
07:41am, Thursday, 16'th Sep 2021
Leap Therapeutics Inc (NASDAQ: LPTX) announced updated data from the first-line cohort of the DisTinGuish Phase 2a trial evaluating DKN-01 combined with BeiGene Ltd's (NASDAQ: BGNE) tislelizumab
Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress
02:31am, Thursday, 16'th Sep 2021
CAMBRIDGE, Mass., Sept. 16, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the
3 Top Penny Stocks to Watch That Are Trending Right Now
09:30am, Tuesday, 14'th Sep 2021
Finding trending penny stocks can be a great strategy to use, here's three to watch The post 3 Top Penny Stocks to Watch That Are Trending Right Now appeared first on Penny Stocks to Buy, Picks, News
Uranium Stocks: Why CCJ, UUUU, UEC, URG, DNN and NXE Are Glowing Up today
12:20pm, Monday, 13'th Sep 2021
Uranium stocks are on the move today and it doesn't have anything to do with specific news from any of the companies in the space. The post Uranium Stocks: Why CCJ, UUUU, UEC, URG, DNN and NXE Are Glo
Why Are Leap Therapeutics Shares Trading Higher On Monday?
09:06am, Monday, 13'th Sep 2021
Leap Therapeutics Inc (NASDAQ: LPTX) stock increased over 30% premarket as the investors are responding positively ahead of the Company's presentation of new data from the first-line cohort of the
LPTX Stock: Why It Increased Today
06:09am, Monday, 13'th Sep 2021
The stock price of Leap Therapeutics Inc (NASDAQ: LPTX) increased over 20% pre-market. This is why it happened.
Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress
06:00am, Monday, 13'th Sep 2021
CAMBRIDGE, Mass., Sept. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Com
4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351%
02:17pm, Wednesday, 08'th Sep 2021
These penny stocks have upcoming events you should know about. The post 4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351% appeared first on Penny Stocks to Buy, Picks, News and Information |
Leap Therapeutics, Inc. (LPTX) Reports Q2 Loss
10:06am, Friday, 13'th Aug 2021
Leap Therapeutics, Inc. (LPTX) delivered earnings and revenue surprises of 7.69% and 0.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation
07:00am, Friday, 13'th Aug 2021
CAMBRIDGE, Mass., Aug. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financi
Leap Therapeutics to Present at the ESMO 2021 Virtual Congress
07:00am, Monday, 26'th Jul 2021
CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Com
Down 19.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Leap Therapeutics, Inc. (LPTX)
11:28am, Monday, 19'th Jul 2021
Leap Therapeutics, Inc. (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earn
Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference
07:00am, Wednesday, 07'th Jul 2021
CAMBRIDGE, Mass., July 7, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dou
Leap Therapeutics to Present at Raymond James 2021 Virtual Human Health Innovation Conference
07:00am, Monday, 14'th Jun 2021
CAMBRIDGE, Mass., June 14, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Do
Leap Therapeutics, Inc. (LPTX) Reports Q1 Loss, Lags Revenue Estimates
09:46am, Friday, 14'th May 2021
Leap Therapeutics, Inc. (LPTX) delivered earnings and revenue surprises of -9.09% and -3.85%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock
